Regenerative Medical Technology (RMTG) Share-based Compensation (2018 - 2022)
Regenerative Medical Technology (RMTG) posted quarterly Share-based Compensation of -$10000.0 for Q4 2022, down 200.0% year-over-year from $10000.0 in Q4 2021, and down 200.0% quarter-over-quarter from $10000.0 in Q4 2021.
Regenerative Medical Technology (RMTG) Share-based Compensation (2018 - 2022) Analysis & Trends
Regenerative Medical Technology's Share-based Compensation history runs 5 years deep, the most recent figure standing at -$10000.0 for Q4 2022.
- In Q4 2022, Share-based Compensation fell 200.0% year-over-year to -$10000.0; the TTM figure through Dec 2025 stood at -$10000.0 (changed N/A YoY), while the FY2025 annual figure was $401.0, changed N/A from the prior year.
- Share-based Compensation for Q4 2022 stood at -$10000.0, down from $10000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $166595.0 in Q2 2020, with the low at -$83064.0 in Q4 2020.
- The 5-year median for Share-based Compensation is $200.0 (2019), against an average of $8150.2.
- The sharpest annual moves came in 2020 and 2022: Share-based Compensation soared 83197.5% in 2020, then plunged 200.0% in 2022.
- Regenerative Medical Technology's Share-based Compensation stood at $1819.0 in 2018, then sank by 89.0% to $200.0 in 2019, then tumbled by 41632.0% to -$83064.0 in 2020, then soared by 112.04% to $10000.0 in 2021, then slumped by 200.0% to -$10000.0 in 2022.
- Business Quant data shows RMTG's Share-based Compensation at -$10000.0 in Q4 2022, $10000.0 in Q4 2021, and $10000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -10,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Dec 31, 2020 | -83,064.00 |
| Dec 31, 2020 | -83,064.00 |
| Jun 30, 2020 | 166,595.00 |
| Jun 30, 2020 | 166,595.00 |
| Mar 31, 2020 | 200.00 |
| Mar 31, 2020 | 200.00 |
| Jun 30, 2019 | 200.00 |
| Jun 30, 2019 | 200.00 |
| Mar 31, 2019 | 200.00 |
| Mar 31, 2019 | 200.00 |
| Dec 31, 2018 | 1,819.00 |
| Dec 31, 2018 | 1,819.00 |